All POLYGON team is happy to be part of the Challenges 2023 selection of 100 start-ups to invest in!​

Thanks to Isabelle de Foucaud for her article. It traces back our path from Polygon creation to the design of our therapeutic candidate and describes the objective of our ongoing fundraising process: to prepare and start the entry into clinical phase during 2024.​

Read the full article here (French only).

‍